ALZN
Price
$1.65
Change
-$0.00 (-0.00%)
Updated
Nov 5, 04:50 PM (EDT)
VRAX
Price
$2.00
Change
-$0.04 (-1.96%)
Updated
Nov 5, 04:00 PM (EDT)
Ad is loading...

ALZN vs VRAX

Header iconALZN vs VRAX Comparison
Open Charts ALZN vs VRAXBanner chart's image
Alzamend Neuro
Price$1.65
Change-$0.00 (-0.00%)
Volume$2.5K
CapitalizationN/A
Virax Biolabs Group
Price$2.00
Change-$0.04 (-1.96%)
Volume$7.84K
CapitalizationN/A
View a ticker or compare two or three
ALZN vs VRAX Comparison Chart
Loading...
ALZN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VRAX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ALZN vs. VRAX commentary
Nov 06, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALZN is a Buy and VRAX is a StrongBuy.

COMPARISON
Comparison
Nov 06, 2024
Stock price -- (ALZN: $1.65 vs. VRAX: $2.03)
Brand notoriety: ALZN and VRAX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALZN: 11% vs. VRAX: 9%
Market capitalization -- ALZN: $7.34M vs. VRAX: $8.64M
ALZN [@Biotechnology] is valued at $7.34M. VRAX’s [@Biotechnology] market capitalization is $8.64M. The market cap for tickers in the [@Biotechnology] industry ranges from $488.28B to $0. The average market capitalization across the [@Biotechnology] industry is $2.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALZN’s FA Score shows that 0 FA rating(s) are green whileVRAX’s FA Score has 1 green FA rating(s).

  • ALZN’s FA Score: 0 green, 5 red.
  • VRAX’s FA Score: 1 green, 4 red.
According to our system of comparison, VRAX is a better buy in the long-term than ALZN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALZN’s TA Score shows that 4 TA indicator(s) are bullish while VRAX’s TA Score has 4 bullish TA indicator(s).

  • ALZN’s TA Score: 4 bullish, 2 bearish.
  • VRAX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ALZN is a better buy in the short-term than VRAX.

Price Growth

ALZN (@Biotechnology) experienced а +1.23% price change this week, while VRAX (@Biotechnology) price change was -8.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.79%. For the same industry, the average monthly price growth was +15.00%, and the average quarterly price growth was +10.61%.

Reported Earning Dates

ALZN is expected to report earnings on Jan 03, 2024.

VRAX is expected to report earnings on Aug 12, 2022.

Industries' Descriptions

@Biotechnology (+4.79% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VRAX($8.79M) has a higher market cap than ALZN($7.38M). VRAX YTD gains are higher at: 38.699 vs. ALZN (-81.461). VRAX has higher annual earnings (EBITDA): -6.9M vs. ALZN (-12.35M). VRAX has more cash in the bank: 5.11M vs. ALZN (283K). VRAX has less debt than ALZN: VRAX (182K) vs ALZN (345K). VRAX has higher revenues than ALZN: VRAX (79.3K) vs ALZN (0).
ALZNVRAXALZN / VRAX
Capitalization7.38M8.79M84%
EBITDA-12.35M-6.9M179%
Gain YTD-81.46138.699-211%
P/E RatioN/AN/A-
Revenue079.3K-
Total Cash283K5.11M6%
Total Debt345K182K190%
TECHNICAL ANALYSIS
Technical Analysis
ALZNVRAX
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 13 days ago
87%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ALZN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VRAX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EFXT6.870.19
+2.84%
Enerflex Ltd
LKQ37.570.67
+1.82%
LKQ Corp
ACHV4.740.03
+0.64%
Achieve Life Sciences
CERT10.24N/A
-0.05%
Certara
LMFA2.63-0.12
-4.36%
LM Funding America

ALZN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALZN has been loosely correlated with SRPT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ALZN jumps, then SRPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALZN
1D Price
Change %
ALZN100%
+0.30%
SRPT - ALZN
49%
Loosely correlated
-0.18%
NCNA - ALZN
43%
Loosely correlated
+0.65%
SNSE - ALZN
41%
Loosely correlated
+6.00%
VRAX - ALZN
40%
Loosely correlated
-0.74%
BPMUF - ALZN
36%
Loosely correlated
N/A
More

VRAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRAX has been loosely correlated with ALZN. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if VRAX jumps, then ALZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRAX
1D Price
Change %
VRAX100%
-0.74%
ALZN - VRAX
40%
Loosely correlated
+0.30%
SNGX - VRAX
36%
Loosely correlated
-6.74%
NCNA - VRAX
36%
Loosely correlated
+0.65%
NTRB - VRAX
31%
Poorly correlated
-3.20%
PTGX - VRAX
30%
Poorly correlated
N/A
More